Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Sabby Capital and Strata Skin Sciences Inc. (SSKN)

Page 1 of 13

Strata Skin Sciences Inc. (NASDAQ:SSKN): Hal Mintz’s Sabby Capital filed an amended 13D.

You can check out Sabby Capital’s latest holdings and filings here.

Please follow Sabby Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Sabby Capital or update its stock holdings.

Hal Mintz
Hal Mintz
Sabby Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sabby Healthcare Master Fund, Ltd 0 335,105 0 335,105 8.2 8.22%
Sabby Volatility Warrant Master Fund, Ltd 0 72,096 0 72,096 72,096 1.77%
Sabby Management 0 407,201 0 407,201 407,201 9.99%
Hal Mintz 0 407,201 0 407,201 407,201 9.99%
Hal Mintz
Hal Mintz
Sabby Capital

Page 1 of 13 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE
13D

Under the Securities Exchange Act of
1934

(Amendment No.   )*

STRATA
SKIN SCIENCES, INC.

(Name of Issuer)

Common
Stock

(Title of Class of Securities)

86272A107

(CUSIP Number)

Robert Grundstein

Sabby Management, LLC

10 Mountainview Road, Suite 205

Upper Saddle River, New Jersey 07458

United States of America

Tel. No.: (646) 307-4500

(Name, Address and Telephone Number of Person
Authorized to
Receive Notices and Communications)

January
2, 2018

(Date of Event Which Requires Filing of
this Statement)

If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box. [X]

Note: Schedules filed in paper format shall include a
signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are
to be sent.

* The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Strata Skin Sciences Inc. (NASDAQ:SSKN)
Trade (NASDAQ:SSKN) Now!
Page 1 of 13
Loading...